TrialHepatology communications2022

Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single-blind, placebo-controlled study in F2/F3 NASH.

Stephen A Harrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.